Physician profile
Shea L Pickering
NPI 1376132852
$940.30
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $760 · 2023: $159 · 2024: $21.64.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $99.99 · Food and Beverage: $80.41.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99.99 |
| Food and Beverage | $80.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $203.98 | 2022 | |
| Sun Pharmaceutical Industries INC. | $187.33 | 2022-2023 | Blu-U |
| Allergan, INC. | $124.43 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $99.99 | 2023 | Sotyktu |
| Genzyme Corporation | $65.25 | 2022-2023 | |
| Amgen INC. | $57.35 | 2022 | |
| Lilly USA, LLC | $44.51 | 2022 | |
| Pfizer INC. | $44.50 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $32.22 | 2022 | |
| Novartis Pharmaceuticals Corporation | $21.85 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $21.64 | 2024 | Libtayo |
| Kci USA, INC. | $19.58 | 2022 | |
| Galderma Laboratories, L.P. | $17.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shea Pickering listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.